JAK3/BTK-IN-1, CAS [[2674036-91-8]]

Produktübersicht

• Artikelname: JAK3/BTK-IN-1, CAS [[2674036-91-8]]
• Artikelnummer: TGM-T9814
• Hersteller Artikelnummer: T9814
• Alternativnummer: TGM-T9814-1MG,TGM-T9814-5MG,TGM-T9814-10MG,TGM-T9814-25MG,TGM-T9814-50MG,TGM-T9814-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

JAK3/ BTk-in-1 is a dual JAK3/BTK inhibitor that specifically targets and inhibits Janus kinase 3 (JAK3) and Brutons tyrosine kinase (BTK), two important targets in autoimmune diseases. JAK3/ BTk-in-1 simultaneously inhibited the BTK/JAK3 signaling pathway, showing a synergistic effect. JAK3/ BTK-in-1 is a potential compound for the treatment of immune-related diseases, such as autoimmune diseases, certain types of cancer (including lymphoma and leukemia), and other diseases that may be characterized by an unbalanced immune response.

Produkteigenschaften

• Molekulargewicht: 456.54
• Reinheit: 97.89%
• CAS Nummer: [2674036-91-8]
• Formel: C25H28N8O
• Target-Kategorie: BTK|||JAK

Bilder

T9814